JP3578455B2 - 局所麻酔を回復させる方法およびそのための薬剤系 - Google Patents

局所麻酔を回復させる方法およびそのための薬剤系 Download PDF

Info

Publication number
JP3578455B2
JP3578455B2 JP50224593A JP50224593A JP3578455B2 JP 3578455 B2 JP3578455 B2 JP 3578455B2 JP 50224593 A JP50224593 A JP 50224593A JP 50224593 A JP50224593 A JP 50224593A JP 3578455 B2 JP3578455 B2 JP 3578455B2
Authority
JP
Japan
Prior art keywords
anesthesia
anesthetic
solution
injection
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP50224593A
Other languages
English (en)
Japanese (ja)
Other versions
JPH06503099A (ja
Inventor
エム. アブラムソーン,グレン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPH06503099A publication Critical patent/JPH06503099A/ja
Application granted granted Critical
Publication of JP3578455B2 publication Critical patent/JP3578455B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP50224593A 1991-07-01 1992-06-26 局所麻酔を回復させる方法およびそのための薬剤系 Expired - Lifetime JP3578455B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72389991A 1991-07-01 1991-07-01
US723,899 1991-07-01
US812,409 1991-12-23
US07/812,409 US5192527A (en) 1991-07-01 1991-12-23 Method of reversing local anesthesia and reagent system therefor
PCT/US1992/005336 WO1993000932A1 (en) 1991-07-01 1992-06-26 Method of reversing local anesthesia and reagent system therefor

Publications (2)

Publication Number Publication Date
JPH06503099A JPH06503099A (ja) 1994-04-07
JP3578455B2 true JP3578455B2 (ja) 2004-10-20

Family

ID=27110888

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50224593A Expired - Lifetime JP3578455B2 (ja) 1991-07-01 1992-06-26 局所麻酔を回復させる方法およびそのための薬剤系

Country Status (11)

Country Link
US (1) US5192527A (cg-RX-API-DMAC7.html)
EP (1) EP0546160B1 (cg-RX-API-DMAC7.html)
JP (1) JP3578455B2 (cg-RX-API-DMAC7.html)
AT (1) ATE200627T1 (cg-RX-API-DMAC7.html)
AU (1) AU658347B2 (cg-RX-API-DMAC7.html)
CA (1) CA2090612C (cg-RX-API-DMAC7.html)
DE (1) DE69231792T2 (cg-RX-API-DMAC7.html)
DK (1) DK0546160T3 (cg-RX-API-DMAC7.html)
ES (1) ES2157904T3 (cg-RX-API-DMAC7.html)
GR (1) GR3036219T3 (cg-RX-API-DMAC7.html)
WO (1) WO1993000932A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994023748A1 (en) * 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
US6008256A (en) * 1995-08-28 1999-12-28 Showa Yakuhin Kako Co., Ltd. Composition for local anesthesia
AU5984801A (en) * 2000-05-12 2001-11-20 Novalar Pharmaceuticals Inc Local anesthetic methods and kits
US7229630B2 (en) * 2002-06-20 2007-06-12 Novalar Pharmaceuticals, Inc. Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof
EP2155214A1 (en) * 2007-05-22 2010-02-24 Glenn Abrahmsohn Method for pain control
US8828452B2 (en) * 2007-05-22 2014-09-09 Glenn Abrahmsohn Method for pain control
US8180446B2 (en) * 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method and system for cyclical neural modulation based on activity state
US8170660B2 (en) 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for thermal modulation of neural activity
US8165669B2 (en) * 2007-12-05 2012-04-24 The Invention Science Fund I, Llc System for magnetic modulation of neural conduction
US8165668B2 (en) * 2007-12-05 2012-04-24 The Invention Science Fund I, Llc Method for magnetic modulation of neural conduction
US8195287B2 (en) * 2007-12-05 2012-06-05 The Invention Science Fund I, Llc Method for electrical modulation of neural conduction
US8170658B2 (en) 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for electrical modulation of neural conduction
US8989858B2 (en) 2007-12-05 2015-03-24 The Invention Science Fund I, Llc Implant system for chemical modulation of neural activity
US8180447B2 (en) 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method for reversible chemical modulation of neural activity
DE102008005469A1 (de) * 2008-01-21 2009-07-23 Kettenbach Gmbh & Co. Kg Pastöses Einsetzmaterial zur Erweiterung des Zahnfleischsulcus und dessen Verwendung
US20090298946A1 (en) * 2008-06-02 2009-12-03 Cleavelin Cody R Local Anesthetic Deactivation
US20130310422A1 (en) 2010-09-01 2013-11-21 The General Hospital Corporation Reversal of general anesthesia by administration of methylphenidate, amphetamine, modafinil, amantadine, and/or caffeine
US8864017B2 (en) 2011-10-13 2014-10-21 Orbis Corporation Plastic corrugated container with improved fold lines and method and apparatus for making same
US9089560B2 (en) 2013-02-01 2015-07-28 Ocularis Pharma, Llc Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
ES2762153T3 (es) 2013-02-01 2020-05-22 Ocuphire Pharma Inc Soluciones oftálmicas acuosas de fentolamina y usos médicos de las mismas
SG11201505907PA (en) * 2013-02-18 2015-08-28 Glenn Abrahmsohn Compositions and methods for pain relief without numbness
SG10201913330SA (en) 2013-09-11 2020-03-30 Glenn Abrahmsohn Hypertonic antimicrobial therapeutic compositions
EP3107551B1 (en) 2014-02-18 2020-10-28 Glenn Abrahmsohn Compositions comprising bicarbonate and calcium salts for pain relief without numbness
KR20210008328A (ko) 2018-03-07 2021-01-21 수부 랩스, 인크. 열 섬유의 자극을 통한 통증 완화 개선을 위한 시스템 및 방법
JP2022508715A (ja) 2018-10-15 2022-01-19 オキュフィア・ファーマ・インコーポレイテッド 緑内障および関連状態の処置のための方法および組成物
JP7670945B2 (ja) 2018-10-26 2025-05-01 オーパス・ジェネティクス・インコーポレイテッド 老眼、散瞳、および他の眼障害の治療のための方法および組成物
WO2020132310A1 (en) 2018-12-19 2020-06-25 The General Hospital Corporation Dextroamphetamine and lisdexamfetamine to reverse dexmedetomidine sedation
CN115368310B (zh) 2021-05-18 2025-06-27 奥库菲尔医药公司 合成甲磺酸酚妥拉明的方法
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method
IL316770A (en) 2022-05-05 2025-01-01 Pfof Llc Nerve block anesthesia and method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746901A (en) * 1954-06-14 1956-05-22 American Home Prod Glycinamide salts
AU513753B2 (en) * 1974-07-08 1980-12-18 Johnson & Johnson Antimicrobial composition
HU172937B (hu) * 1975-12-18 1979-01-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh khondroitin-sernoj kisloty s mestno anestezirujuhhim ehffektom
US4476115A (en) * 1983-07-05 1984-10-09 Reed Raymond E Analgesic composition and method of treating subdermal pain
US4659714A (en) * 1984-03-27 1987-04-21 Dentsply, Ltd. Anesthetic methods for mammals
US4963345A (en) * 1988-07-18 1990-10-16 Forrest Kim K Injectable local anesthetic antidote
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products

Also Published As

Publication number Publication date
CA2090612A1 (en) 1993-01-02
WO1993000932A1 (en) 1993-01-21
JPH06503099A (ja) 1994-04-07
DE69231792T2 (de) 2001-11-15
CA2090612C (en) 2007-05-29
GR3036219T3 (en) 2001-10-31
ATE200627T1 (de) 2001-05-15
AU658347B2 (en) 1995-04-06
EP0546160A4 (cg-RX-API-DMAC7.html) 1994-04-06
ES2157904T3 (es) 2001-09-01
AU2294892A (en) 1993-02-11
DE69231792D1 (de) 2001-05-23
US5192527A (en) 1993-03-09
EP0546160B1 (en) 2001-04-18
EP0546160A1 (en) 1993-06-16
DK0546160T3 (da) 2001-07-30

Similar Documents

Publication Publication Date Title
JP3578455B2 (ja) 局所麻酔を回復させる方法およびそのための薬剤系
US9192575B2 (en) Sustained-release liposomal anesthetic compositions
US5261903A (en) Composite anesthetic article and method of use
US5209724A (en) Composite anesthetic article and method of use
CA1202240A (en) Transdermal 2-(4-isobutylphenyl)-propionic acid medication and methods
JP2007507538A5 (cg-RX-API-DMAC7.html)
WO2002022128A1 (en) A method of local anesthesia and analgesia
EP0296236A1 (en) Nasal delivery of caffeine
JP3597333B2 (ja) 急性鼻炎を処置するための医薬製剤
US5226901A (en) Composite anesthetic article and method of use
JP2007291067A (ja) 医薬組成物
JP2005531528A5 (cg-RX-API-DMAC7.html)
JPH0640947A (ja) 経皮吸収製剤用組成物および経皮吸収製剤
Adriani et al. Some recent studies on the clinical pharmacology of local anesthetics of practical significance
Kramer et al. Overview of local anesthesia
KR100262177B1 (ko) 동통 처치용 조성물, 동통 처치 방법 및 동통 경감작용 증강조성물
JP4829478B2 (ja) 医薬組成物
WO1993017674A1 (en) Topical use of local anaesthetic agents for rheumatoid arthritis as well as a pharmaceutical preparation and a method for the treatment thereof
EP0542988B1 (en) Improved euthanasia compositions
JP2020519593A (ja) 溶解度を増強させた薬物含有製剤
Hernández-Cortez et al. Local Anesthetics in Odontology
NO863082L (no) Preparat for intramuskulaer injeksjon av legemidler, vitaminer eller vaksiner.
US11992484B2 (en) Analgesic formulations and methods for reduced postoperative nausea and vomiting and enhanced postoperative pain relief
KR930701994A (ko) 개선된 진통 효과를 제공하는 방법
US6110954A (en) Treatment

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040615

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040713

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090723

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090723

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100723

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100723

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110723

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120723

Year of fee payment: 8

EXPY Cancellation because of completion of term